About Bone morphogenetic protein 4
Bone morphogenetic protein 4 (BMP4) is a protein
from Homo sapiens identified by UniProt accession
P12644, 408 residues long.
MolForge cross-references it against 0 known binders and
1,049 disease associations.
Target properties
| Protein name | Bone morphogenetic protein 4 |
| UniProt accession | P12644 |
| Gene | BMP4 |
| Organism | Homo sapiens |
| Length | 408 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (1049)
Diseases linked to this target (Open Targets).
- microphthalmia with brain and digit anomalies · score 0.79
- orofacial cleft 11 · score 0.73
- heel bone mineral density · score 0.52
- refractive error measurement · score 0.48
- bone quantitative ultrasound measurement · score 0.47
- colorectal cancer · score 0.47
- Stickler syndrome · score 0.46
- neurodegenerative disease · score 0.46
- FEV/FVC ratio · score 0.46
- refractive error · score 0.45
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P12644-F1 | alphafold | PREDICTED | 78.51 | — |
Amino-acid sequence (408 residues)
MIPGNRMLMV VLLCQVLLGG ASHASLIPET GKKKVAEIQG HAGGRRSGQS HELLRDFEAT LLQMFGLRRR PQPSKSAVIP DYMRDLYRLQ SGEEEEEQIH STGLEYPERP ASRANTVRSF HHEEHLENIP GTSENSAFRF LFNLSSIPEN EVISSAELRL FREQVDQGPD WERGFHRINI YEVMKPPAEV VPGHLITRLL DTRLVHHNVT RWETFDVSPA VLRWTREKQP NYGLAIEVTH LHQTRTHQGQ HVRISRSLPQ GSGNWAQLRP LLVTFGHDGR GHALTRRRRA KRSPKHHSQR ARKKNKNCRR HSLYVDFSDV GWNDWIVAPP GYQAFYCHGD CPFPLADHLN STNHAIVQTL VNSVNSSIPK ACCVPTELSA ISMLYLDEYD KVVLKNYQEM VVEGCGCR
Explore Bone morphogenetic protein 4 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets